Data from second independent multi-center study of patients with high-risk cutaneous squamous cell carcinoma confirms independent risk-stratification performance of decisiondx®-scc

Friendswood, texas--(business wire)---- $cstl #cstl--new data presented at acms confirms independent risk-stratification performance of castle's decisiondx®-scc test.

CSTL Ratings Summary

CSTL Quant Ranking